Rivaroxaban Zentiva10 mg film-coated tablets EFG
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the Package Leaflet
Rivaroxaban Zentiva contains the active substance rivaroxaban and is used in adults to:
Rivaroxaban Zentiva belongs to a group of medicines called antithrombotic agents. It works by blocking a clotting factor (factor Xa) and thus reducing the tendency of blood to form clots.
Do not take Rivaroxaban Zentiva
Do not take Rivaroxaban Zentiva and inform your doctorif any of these circumstances apply to you.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Rivaroxaban Zentiva.
Be particularly careful with Rivaroxaban Zentiva
Inform your doctor if you have any of these conditionsbefore taking Rivaroxaban Zentiva. Your doctor will decide if you should be treated with this medication and if you should be kept under closer observation.
If you need surgery
Children and adolescents
Rivaroxaban Zentiva 10 mg tablets are not recommended for children under 18 years of age. There is not enough information available on its use in children and adolescents.
Other medications and Rivaroxaban Zentiva
Inform your doctor or pharmacist if you are using, have recently used, or may need to use any other medication, including those purchased without a prescription.
If any of the above circumstances apply to you, inform your doctorbefore taking Rivaroxaban Zentiva, as the effect of Rivaroxaban Zentiva may be increased. Your doctor will decide if you should be treated with this medication and if you should be kept under closer observation.
If your doctor considers that you have a higher risk of developing stomach or intestinal ulcers, they will recommend that you also use an ulcer prevention treatment.
If any of the above circumstances apply to you, inform your doctorbefore taking Rivaroxaban Zentiva, as the effect of Rivaroxaban Zentiva may be decreased. Your doctor will decide if you should be treated with Rivaroxaban Zentiva and if you should be kept under closer observation.
Pregnancy and breastfeeding
Do not take Rivaroxaban Zentiva if you are pregnant or breastfeeding. If there is any possibility that you may become pregnant, use a reliable contraceptive while taking Rivaroxaban Zentiva. If you become pregnant while taking this medication, inform your doctor immediately, who will decide how you should be treated.
Driving and using machines
Rivaroxaban Zentiva may cause dizziness (a common side effect) or fainting (an uncommon side effect) (see section 4, "Possible side effects"). You should not drive, ride a bicycle, or use tools or machines if you are affected by these symptoms.
Rivaroxaban Zentiva contains lactose and sodium
If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
This medication contains less than 1 mmol of sodium (23 mg) per tablet; i.e., it is essentially "sodium-free".
Follow the instructions for administration of this medication exactly as indicated by your doctor. If you are in doubt, consult your doctor or pharmacist again.
What dose to take
The recommended dose is one Rivaroxaban Zentiva 10 mg tablet once a day.
After at least 6 months of treatment for blood clots, the recommended dose is one 10 mg tablet once a day or one 20 mg tablet once a day. Your doctor has prescribed Rivaroxaban Zentiva 10 mg once a day.
Swallow the tablet preferably with water.
Rivaroxaban Zentiva can be taken with or without food.
If you have difficulty swallowing the tablet whole, consult your doctor about other ways to take Rivaroxaban Zentiva. The tablet can be crushed and mixed with water or apple sauce, immediately before taking it.
If necessary, your doctor may also administer the crushed Rivaroxaban Zentiva tablet through a gastric tube.
When to take Rivaroxaban Zentiva
Take the tablet every day, until your doctor indicates otherwise.
Try to take a tablet at the same time every day to help you remember.
Your doctor will decide how long you should continue taking the treatment.
To prevent the formation of blood clots in the veins after hip or knee replacement surgery:
Take the first tablet 6 to 10 hours after surgery.
If you have undergone major hip surgery, you will usually take the tablets for 5 weeks.
If you have undergone major knee surgery, you will usually take the tablets for 2 weeks.
If you take more Rivaroxaban Zentiva than you should
Call your doctor immediately if you have taken too many Rivaroxaban Zentiva tablets. Taking too much Rivaroxaban Zentiva increases the risk of bleeding.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Rivaroxaban Zentiva
If you forget to take a dose, take it as soon as you remember. Take the next tablet the following day and, after that, continue taking one tablet every day, as usual.
Do not take a double dose to make up for forgotten doses.
If you interrupt treatment with Rivaroxaban Zentiva
Do not interrupt treatment with Rivaroxaban Zentiva without first talking to your doctor, as Rivaroxaban Zentiva prevents the development of a serious condition.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, Rivaroxaban Zentiva can cause side effects, although not everyone gets them.
Like other similar medications to reduce blood clotting, Rivaroxaban Zentiva can cause bleeding, which can be life-threatening. Excessive bleeding can cause a sudden drop in blood pressure (shock). In some cases, the bleeding may not be apparent.
Tell your doctor immediately if you experience any of the following side effects:
Your doctor will decide to keep you under closer observation or modify your treatment.
The frequency of these side effects is very rare (up to 1 in 10,000 people).
The frequency of severe allergic reactions is very rare (anaphylactic reactions, including anaphylactic shock; may affect up to 1 in 10,000 people) and uncommon (angioedema and allergic edema; may affect up to 1 in 100 people).
General list of possible side effects
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Very rare(may affect up to 1 in 10,000 people)
Frequency not known(cannot be estimated from the available data)
Reporting side effects
If you experience any side effects, consult your doctor or pharmacist, even if they are side effects not listed in this package leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: www.notificaRAM.es.
By reporting side effects, you can help provide more information on the safety of this medication.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and on the blister after “EXP”. The expiry date refers to the last day of the month stated.
This medicine does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Dispose of the packaging and any unused medicine in the SIGRE collection point at your pharmacy. If you are unsure, ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.
Composition of Rivaroxaban Zentiva
Appearance and Package Contents of the Product
Rivaroxaban Zentiva 10 mg film-coated tablets are pink, round, biconvex, film-coated (approximately 8.4 mm in diameter), with “10” embossed on one side and smooth on the other side.
Rivaroxaban Zentiva 10 mg is available in packs of 5, 10, 15, 20, 30, 98, and 100 film-coated tablets.
Not all pack sizes may be marketed.
Marketing Authorisation Holder
Zentiva k.s.
U Kabelovny 130,
Dolní Mecholupy
102 37 Prague 10
Czech Republic
Manufacturer
Pharmadox Healthcare Ltd.
KW20A Kordin Industrial Park
Paola
PLA3000 Malta
or
S.C Zentiva S.A.
B-dul Theodor Pallady nr. 50,
sector 3,
Bucharest, cod 032266
Romania
You can request more information about this medicine by contacting the local representative of the marketing authorisation holder:
Zentiva Spain S.L.U.
Avenida de Europa, 19, Edificio 3, Planta 1.
28224 Pozuelo de Alarcón, Madrid
Spain
This medicine is authorised in the Member States of the European Economic Area under the following names:
Czech Republic, Austria, Denmark, Spain, Hungary, Iceland, Norway, Netherlands, Sweden, and Germany: Rivaroxaban Zentiva
Croatia: Rivaroksaban Zentiva
France: RIVAROXABAN ZENTIVA
Italy: Rivaroxaban Zentiva Italia
Portugal: Rivaroxabano Zentiva
Date of last revision of this leaflet:December 2023
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es